Baxter International Inc. (BAX) Stock
BAX Key Statistics
About Baxter International Inc.
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
CEO: Andrew Hider. Company website
BAX — Frequently Asked Questions
What is the BAX stock price today?
Baxter International Inc. (BAX) trades at $22.80, down 0.96% on the day, as of Sep 20, 2026 14:59 UTC.
What is Baxter International Inc.'s market cap?
Baxter International Inc. has a market capitalisation of $11.79B, calculated from the live BAX share price and shares outstanding.
What is the P/E ratio of BAX?
BAX has no meaningful price-to-earnings ratio: Baxter International Inc. lost $2.04 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Baxter International Inc. make?
Baxter International Inc. generated revenue of $11.47B over the trailing twelve months, which puts the stock at 1.03 times sales.
Does BAX pay a dividend?
Yes. Baxter International Inc. pays a dividend yielding 2.62% on the current share price.
What is the 52-week range for BAX?
BAX has traded between $15.73 and $30.00 over the past 52 weeks, and the last price is 24.0% below that high.
Is Baxter International Inc. profitable?
No. Baxter International Inc. is loss-making, with a net margin of -9.27% over the trailing twelve months.
What is the analyst price target for BAX?
Wall Street analysts rate BAX Hold, with an average price target of $25.00, 9.6% above the current price.
What sector is Baxter International Inc. in?
Baxter International Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of Baxter International Inc.?
Andrew Hider is the chief executive of Baxter International Inc., which employs 37,500 people.
Where can I track BAX in real time?
QFI Terminal shows BAX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See BAX live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open BAX in Terminal See plans